secwatch.observer — SEC 8-K summary
======================================

Issuer:     ProPhase Labs, Inc. (PRPH)
CIK:        0000868278
Form:       8-K/A
Filed at:   2025-06-27T23:59:59+00:00
Accession:  0001641172-25-016815
Event type: debt
Sentiment:  negative
Materiality: 0.60
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ProPhase Labs enters $1M bridge loan (20% OID) from CEO and investor; issues warrants
--------------------------------------------------------------------------------

- Each loan (CEO and investor) $500k principal, 20% OID ($625k face), 10% interest, 12-month maturity.
- Company issued 500,000 unvested warrants per loan (1M total) at $0.60/share, vesting conditional on shareholder approval.
- Loans secured but subordinate to up to $6M senior debt; proceeds for working capital; repayment via Nebula Genomics sale or Crown Medical collections.
- CEO loan is related-party transaction; Audit Committee approved; Karkus receives $10,000 expense reimbursement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/868278/000164117225016815/0001641172-25-016815-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/868278/000164117225016815/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-016815

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer